MMWR Morb Mortal Wkly Rep. 2002 Nov 15;51(45):1019-24.
Two vaccine-preventable diseases, influenza and pneumococcal disease, contribute to the mortality of older persons in the United States. Influenza caused an average of 20,000 deaths per year during influenza epidemics in the United States from 1969 to 1996; persons aged > or = 65 years accounted for approximately 90% of these deaths. Pneumococcal disease caused approximately 3,400 deaths among persons aged > or = 65 years in the United States in 1998. National health objectives for 2010 include increasing influenza and pneumococcal vaccination levels to > or = 90% among persons aged > or = 65 years (objective nos. 14.29a and 14.29b, respectively). To assess progress toward achieving these objectives, CDC analyzed data from the 2001 Behavioral Risk Factor Surveillance System (BRFSS). This report summarizes the results, which indicate that the estimated point prevalences of influenza and pneumococcal vaccination were <80% among persons aged > or = 65 years in all reporting areas. Influenza vaccination levels during 2000-2001 decreased from 1998-1999 levels in 27 of 52 reporting areas; pneumococcal vaccination prevalence increased a median of 7 percentage points from 1999 to 2001. Continued efforts are needed to increase the proportion of older adults who receive influenza and pneumococcal vaccines; health-care providers should offer pneumococcal vaccine all year and should continue to offer influenza vaccine during December and throughout the influenza season, even after influenza activity has been documented in the community.
两种可通过疫苗预防的疾病,即流感和肺炎球菌疾病,在美国导致老年人死亡。1969年至1996年期间,在美国流感流行期间,流感平均每年导致20,000人死亡;年龄≥65岁的人群约占这些死亡人数的90%。1998年,肺炎球菌疾病在美国≥65岁的人群中导致约3,400人死亡。2010年的国家卫生目标包括将≥65岁人群的流感和肺炎球菌疫苗接种率提高到≥90%(分别为目标编号14.29a和14.29b)。为评估实现这些目标的进展情况,美国疾病控制与预防中心(CDC)分析了2001年行为危险因素监测系统(BRFSS)的数据。本报告总结了结果,结果表明,在所有报告地区,≥65岁人群中流感和肺炎球菌疫苗接种的估计时点患病率均低于80%。在52个报告地区中的27个地区,2000 - 2001年期间的流感疫苗接种率低于1998 - 1999年的水平;肺炎球菌疫苗接种率从1999年到2001年中位数上升了7个百分点。需要继续努力提高接种流感和肺炎球菌疫苗的老年人比例;医疗服务提供者应全年提供肺炎球菌疫苗,并应在12月及整个流感季节继续提供流感疫苗,即使社区已记录到流感活动。